What is the link between endometriosis and infertility?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

The Link Between Endometriosis and Infertility

Endometriosis affects at least one-third of women with infertility and up to 50% of women with endometriosis experience infertility, though the precise mechanisms remain incompletely understood. 1, 2, 3

Prevalence and Association

  • Endometriosis is present in approximately one-third of infertile women, making it one of the most common identifiable causes of female infertility alongside ovulatory failure (21%) and tubal damage (14%). 1
  • Up to 50% of women diagnosed with endometriosis will experience infertility, establishing a strong bidirectional association between the two conditions. 2, 3
  • The disease affects approximately 10% of reproductive-aged women worldwide, representing an estimated 176 million women globally. 1, 2

Pathophysiological Mechanisms

The mechanisms linking endometriosis to infertility are multifactorial and include anatomical distortion, chronic inflammation, ovarian dysfunction, and impaired endometrial receptivity. 4, 5

Anatomical and Structural Factors

  • Pelvic adhesions and fibrosis from endometriosis create anatomical distortions that mechanically interfere with ovum pickup by the fallopian tubes and normal tubal function. 4, 5
  • Deep infiltrating endometriosis (lesions extending >5 mm beneath the peritoneal surface or involving bowel, bladder, ureter, or vagina) can cause severe anatomical disruption affecting reproductive organs. 1, 6
  • Tubal occlusion and peritubular adhesions develop in women with a history of endometriosis-related pelvic inflammation, directly preventing fertilization. 1

Inflammatory and Immunological Mechanisms

  • Chronic niche inflammation in the peritoneal cavity, ovaries, and uterus creates a hostile environment for conception through multiple pathways. 2, 4
  • The inflammatory milieu produces cytokines and immune mediators that impair oocyte quality, sperm function, fertilization, and embryo development. 2, 4
  • Endometriosis is fundamentally an estrogen-dependent inflammatory disease characterized by chronic inflammation that systemically affects reproductive function. 6, 7

Ovarian Dysfunction

  • Endometriosis disrupts normal ovarian reserve and function, leading to ovulatory dysfunction even in women with regular menstrual cycles. 4, 5
  • Ovarian endometriomas (endometriosis cysts) directly damage ovarian tissue and reduce the pool of viable follicles. 4
  • The disease affects oocyte quality through inflammatory mediators and oxidative stress within the ovarian microenvironment. 2, 4

Endometrial and Implantation Defects

  • Compromised endometrial receptivity represents a key mechanism, particularly in women with minimal or mild disease where anatomical factors are absent. 4, 3
  • Endometrial changes associated with endometriosis create an inhospitable environment for embryo implantation, even when fertilization occurs successfully. 3
  • The progesterone resistance characteristic of endometriosis impairs normal endometrial preparation for implantation. 6, 7

Clinical Implications

Heterogeneity of Presentation

  • The population of infertile women with endometriosis is highly heterogeneous, with diverse phenotypes making it difficult to establish a single mechanism or predict individual fertility outcomes. 4
  • The extent of disease (as measured by r-ASRM staging) correlates poorly with fertility outcomes, meaning severe anatomical disease does not necessarily predict worse fertility prognosis. 1, 6
  • Women with minimal or mild peritoneal endometriosis may experience significant infertility despite minimal visible disease, suggesting inflammatory and molecular mechanisms predominate over anatomical factors in these cases. 3, 5

Assisted Reproductive Technology Outcomes

  • Endometriosis is associated with poorer outcomes in assisted reproductive technology (ART), including decreased oocyte retrieval numbers, lower implantation rates, and reduced pregnancy rates compared to other causes of infertility. 2
  • In vitro fertilization (IVF) remains effective for women with less-advanced endometriosis, achieving success rates similar to other infertility causes. 5
  • Women with more advanced stages of endometriosis (stage III-IV) have demonstrably lower IVF success rates compared to those with minimal or mild disease. 5

Common Pitfalls in Understanding the Link

  • Do not assume that the severity of pain symptoms correlates with the degree of infertility—these are independent manifestations of the disease with different underlying mechanisms. 1, 6
  • Avoid concluding that absence of visible endometriosis on imaging or laparoscopy rules out endometriosis-associated infertility, as small peritoneal implants causing significant inflammatory effects are poorly detected by current imaging modalities. 1
  • Do not overlook that approximately 28% of infertile couples have unexplained infertility, and undiagnosed minimal endometriosis may account for a substantial portion of these cases. 1

Systemic Nature of the Disease

  • Endometriosis should be understood as a systemic disease rather than solely a pelvic condition, with multifactorial etiology including genetic factors, possible epigenetic influences, and environmental exposures. 1, 6
  • The disease exhibits hormone-responsive behavior with estrogen-dependence and progesterone resistance, maintaining itself through autonomous local estrogen synthesis independent of ovarian production. 6, 7
  • This systemic inflammatory state has pleiotropic direct and indirect effects on reproduction that extend beyond localized pelvic pathology. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Endometriosis and infertility.

Clinical obstetrics and gynecology, 2010

Guideline

Endometriosis: Definition, Clinical Implications, and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Endometriosis and Estrogen Production

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What are the possible causes of a poorly defined endo-myometrial junction (EMJ) in a woman of likely childbearing age with primary infertility, normal hysteroscopy (Hysteroscopic Resection of the Uterus) findings except for a slightly lengthy posterior wall of the uterus, from day 3 of a Hormone Replacement Therapy (HRT) Frozen Embryo Transfer (FET) cycle?
What are the chances of pregnancy for a patient with endometriosis?
Does endometriosis impact fertility?
Does having a surgical abortion decrease fertility odds in a female patient of reproductive age with severe endometriosis?
What is the most likely diagnosis for a female patient of reproductive age with a history of infertility, presenting with severe dysmenorrhea unrelieved by naproxen (nonsteroidal anti-inflammatory drug)?
In a typical adult with normal hepatic and renal function, how long after stopping amlodipine 2.5 mg does it no longer have a significant antihypertensive effect?
What is the recommended initial assessment, diagnostic workup, and empiric treatment for a child with suspected central nervous system infection, including infants and older children?
What medications are recommended for an older adult with Alzheimer-type dementia presenting with cognitive decline?
What is the recommended evaluation and management for an elevated serum iron level?
What non‑sedating, weight‑neutral anxiolytic is appropriate for a 35‑year‑old woman with generalized anxiety disorder whose anxiety has worsened despite escitalopram (Lexapro) 20 mg daily?
How should I prescribe a compounded ABH (lorazepam, diphenhydramine, haloperidol) topical gel for hospice or palliative‑care patients with breakthrough nausea, vomiting, or terminal delirium refractory to oral anti‑emetics?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.